Company Announcements

Total Voting Rights

Source: RNS
RNS Number : 1905D
Craneware plc
05 October 2018

Craneware plc

("Craneware" or the "Company")


Total Voting Rights


In accordance with the Disclosure and Transparency Rules, Craneware announces that at the date of this notice its issued share capital comprises 26,698,984 ordinary shares of 1p ("Ordinary Shares") each with voting rights.


No Ordinary Shares are held in treasury.


The total voting rights in the Company is therefore 26,698,984. The voting rights of all of the Ordinary Shares are identical.


The figure above may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Craneware, under the Disclosure and Transparency Rules.



For further information, please contact:


Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO / Craig Preston, CFO


Peel Hunt (NOMAD and Joint Broker)

+44 (0)20 7418 8900

Dan Webster/ George Sellar


Investec Bank (Joint Broker)

+44 (0) 20 7597 5970

Patrick Robb/ Sebastian Lawrence/ Henry Reast


Alma (Financial PR)

+44 (0)208 004 4217

Caroline Forde/ Robyn Fisher/ Josh Royston



About Craneware


Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.


Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit and


 Learn more at



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit